Reina N. Fuji
Impact Assessment(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Alzheimer's disease research and treatments, Click Chemistry and Applications, CAR-T cell therapy research
Most-Cited Works
- → Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates(2012)980 cited
- → Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation(2010)813 cited
- → Effect of selective LRRK2 kinase inhibition on nonhuman primate lung(2015)364 cited
- → Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer(2010)290 cited
- → Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier(2013)261 cited
- → ABBY(2018)248 cited
- → Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection(2009)248 cited
- → Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease(2022)178 cited
- → Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors(2012)161 cited
- → Evolutionary conservation of histone macroH2A subtypes and domains(1998)151 cited